European Leukemia Trial Registry
Trial: CML Dasatinib in CML chronic phase

More Details
Short Title CML Dasatinib in CML chronic phase
Trialgroup CML-Studiengruppe
Type of Trial randomized
Disease Chronic myeloid leukemia(CML) Chronic Phase
Age >= 18 years
Status Closed
Start of Recruitment 01.01.2005
Leader Hochhaus, Prof. Dr. med., Andreas
Contactperson

General Contact Person
Fischer, Prof. Dr. med., Thomas
Tel: +49 (0)391 67-13266
Fax: +49 (0)391 67-13267
Email: thomas.fischer@med.ovgu.de
Homepage: http://www.med.uni-magdeburg.de/KHAE.html

General Contact Person
Niederwieser, Prof. Dr. med. Dr. h.c., Dietger
Tel: +49 (0)341 971 3050
Fax: +49 (0)341 971 3059
Email: dietger@medizin.uni-leipzig.de

General Contact Person
Ehninger, Prof. Dr. med., Gerhard
Tel: +49 (0)351 458 4251
Fax: +49 (0)351 458 4367
Email: gerhard.ehninger@uniklinikum-dresden.de

General Contact Person
Ottmann, Prof. Dr., Oliver
Tel: +49 (0)69 6301 87070
Fax: +49 (0)69 6301 4170
Email: ottmann@em.uni-frankfurt.de

General Contact Person
Brümmendorf, Prof. Dr. med., Tim H.
Tel: +49 (0)241 80-89805
Fax: +49 (0)241 80-82449
Email: tbruemmendorf@ukaachen.de

Centre of Trial Medizinische Fakultät Mannheim der Universität Heidelberg
Shortprotocol Shortprotocol
created 29.06.2006 Anja Hellenbrecht
changed 27.09.2010 Silvia Schäfer
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org